You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 10, October 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Invited Critique
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Endocrine Surgery
 •Prognosis/ Outcomes
 •Endocrine Diseases
 •Thyroid/ Parathyroid Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Changing Trends and Prognoses for Patients With Papillary Thyroid Cancer—Invited Critique

Martha A. Zeiger, MD
Baltimore, Md

Arch Surg. 1998;133:1065.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The findings reported by Yamashita et al are due to a multitude of factors. The increase in age of patients given a diagnosis of papillary thyroid cancers during 3 consecutive decades is likely secondary to the increased longevity experienced by the overall population. Two factors exist that may contribute to the decrease in tumor size seen over time: (1) ultrasonography is more readily available and thereby identifies lesions that are smaller and not obvious clinically; and (2) fine needle aspiration biopsy, introduced during the 1950s, is more universally available and also can identify cancers at an earlier stage. The improvement in disease-specific survival is probably secondary to a change in the reported overall treatment of these patients. First, by identifying lesions at an earlier stage, one introduces the concept of lead-time bias, which can contribute to perceived overall improved survival. Second, the authors report an increase . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Changing Trends and Prognoses for Patients With Papillary Thyroid Cancer
Hiroyuki Yamashita, Shiro Noguchi, Hiroto Yamashita, Nobuo Murakami, Shin Watanabe, Shinya Uchino, Hitoshi Kawamoto, Masakatsu Toda, and Iwao Nakayama
Arch Surg. 1998;133(10):1058-1065.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.